These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 24919269)

  • 41. Retrospective study of patients with pathologic N1-stage II non-small cell lung cancer.
    Nakagawa T; Okumura N; Kokado Y; Miyoshi K; Matsuoka T; Kameyama K
    Interact Cardiovasc Thorac Surg; 2007 Aug; 6(4):474-8. PubMed ID: 17669909
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparison of survival and disease-specific survival in surgically resected, lymph node-positive bronchioloalveolar carcinoma versus nonsmall cell lung cancer: implications for adjuvant therapy.
    Varlotto JM; Flickinger JC; Recht A; Nikolov MC; DeCamp MM
    Cancer; 2008 Apr; 112(7):1547-54. PubMed ID: 18260087
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Incidence of lymph node involvement in pN2 non-small cell lung carcinoma and reevaluation of the lymph node dissection method].
    Shiba M; Yamaguchi Y; Takeda T
    Kyobu Geka; 1994 Jan; 47(1):33-6. PubMed ID: 8277629
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lung cancer and its operable brain metastasis: survival rate and staging problems.
    Furák J; Troján I; Szöke T; Agócs L; Csekeö A; Kas J; Svastics E; Eller J; Tiszlavicz L
    Ann Thorac Surg; 2005 Jan; 79(1):241-7; discussion 241-7. PubMed ID: 15620950
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Sleeve resection for lung cancer: a report of 82 cases].
    Chen PC; Zhou XM; Chen QX; Liu JS; Yan FL; Jiang YH
    Ai Zheng; 2008 May; 27(5):510-5. PubMed ID: 18479601
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The prognostic impact of main bronchial lymph node involvement in non-small cell lung carcinoma: suggestions for a modification of the staging system.
    Shimada Y; Tsuboi M; Saji H; Miyajima K; Usuda J; Uchida O; Kajiwara N; Ohira T; Hirano T; Kato H; Ikeda N
    Ann Thorac Surg; 2009 Nov; 88(5):1583-8. PubMed ID: 19853116
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Technical innovations of carinal resection for nonsmall-cell lung cancer.
    Macchiarini P; Altmayer M; Go T; Walles T; Schulze K; Wildfang I; Haverich A; Hardin M;
    Ann Thorac Surg; 2006 Dec; 82(6):1989-97; discussion 1997. PubMed ID: 17126096
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Conditional cancer-specific versus cardiovascular-specific survival after lobectomy for stage I non-small cell lung cancer.
    Groth SS; Rueth NM; Hodges JS; Habermann EB; Andrade RS; D'Cunha J; Maddaus MA
    Ann Thorac Surg; 2010 Aug; 90(2):375-82. PubMed ID: 20667314
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Prognostic analysis of N2 non-small cell lung cancer].
    Ma QL; Liu DR; Guo YQ; Shi B; Song ZY; Tian YC
    Zhonghua Wai Ke Za Zhi; 2009 Jul; 47(14):1058-60. PubMed ID: 19781268
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Segmentectomy and Lung Cancer: Why, When, How, and How Good?
    Landreneau RJ; D'Amico TA; Schuchert MJ; Swanson SJ
    Semin Thorac Cardiovasc Surg; 2017; 29(1):119-128. PubMed ID: 28683989
    [No Abstract]   [Full Text] [Related]  

  • 51. Prolonged survival after extracranial metastasectomy from synchronous resectable lung cancer.
    Ambrogi V; Tonini G; Mineo TC
    Ann Surg Oncol; 2001 Sep; 8(8):663-6. PubMed ID: 11569782
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Outcomes after lobectomy and pneumonectomy in lungcancer patients aged 70 years or older.
    Aytekin İ; Şanli M; Işik AF; Tunçözgür B; Uluşan A; Bakir K; Kul S; Elbeyli L
    Turk J Med Sci; 2017 Feb; 47(1):307-312. PubMed ID: 28263507
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Better Survival After 4L Lymph Node Dissection for Early-Stage, Left-Sided, Non-small Cell Lung Cancer: Are We Debating a False Duality?
    Reinersman JM
    Ann Surg Oncol; 2019 Jul; 26(7):1959-1960. PubMed ID: 31016484
    [No Abstract]   [Full Text] [Related]  

  • 54. Functional outcomes after lung cancer resection: who cares as long as you are cured?
    Handy JR
    Chest; 2009 Feb; 135(2):258-259. PubMed ID: 19201706
    [No Abstract]   [Full Text] [Related]  

  • 55. Importance of biologic status to the postoperative prognosis of patients with stage III nonsmall cell lung cancer.
    Nakahara K; Monden Y; Ohno K; Fujii Y; Hashimoto J; Kitagawa Y; Kawashima Y
    J Surg Oncol; 1987 Nov; 36(3):155-60. PubMed ID: 2824933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Factors affecting survival of radically operated nonsmall cell lung cancer patients of 70 years and older].
    Mikhnin AE; Preis VG; Arseniev AI; Chimitova EV; Semenova MA
    Vopr Onkol; 2016; 62(1):154-65. PubMed ID: 30444595
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Do Margins Really Affect Prognosis in Wedge Resection for Early-Stage Lung Cancer?
    Baisi A; Raveglia F; De Simone M; Cioffi U
    Ann Thorac Surg; 2016 Apr; 101(4):1629. PubMed ID: 27000595
    [No Abstract]   [Full Text] [Related]  

  • 58. [Non-small-cell bronchopulmonary carcinoma without adenopathy. Value of mediastinal lymph node excisions].
    Manac'h D; Riquet M; Lepimpec-Barthes F; Debrosse D; Marin I; Debesse B
    Presse Med; 1994 Mar; 23(10):493. PubMed ID: 8022734
    [No Abstract]   [Full Text] [Related]  

  • 59. [Completion pneumonectomy. Indications and results].
    Jungraithmayr W; Hasse J; Olschewski M; Stoelben E
    Chirurg; 2005 Feb; 76(2):157-66. PubMed ID: 15258743
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The evolution of surgery in non-small cell lung cancer.
    Alloisio M; Infante M; Cariboni U; Testori A; Soto Parra H; Ravasi G
    Tumori; 2000; 86(5 Suppl 1):S42-6. PubMed ID: 11195294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.